Barriers and facilitators to the administration of prehospital tranexamic acid: a paramedic interview study using the

Laura Goodwin1, Helen Nicholson2, Maria Robinson3

  • 1Health and Applied Sciences, University of the West of England, Bristol, UK laura.goodwin@uwe.ac.uk.

Insights

Low rates of prehospital tranexamic acid (TXA) administration in trauma patients are linked to knowledge gaps, guideline confusion, resource limitations, and challenges in identifying bleeding risk. Addressing these barriers is key to improving TXA use by paramedics.

Area of Science:

  • Emergency medicine
  • Trauma care
  • Pharmaceutical interventions

Background:

  • Tranexamic acid (TXA) is an antifibrinolytic drug crucial for preventing bleeding in trauma patients.
  • Despite evidence, prehospital TXA administration rates in the UK remain low.
  • This study investigates barriers and facilitators to TXA use by UK paramedics.

Purpose of the Study:

  • To identify barriers and facilitators to prehospital tranexamic acid (TXA) administration.
  • To understand the factors influencing paramedics' decisions to administer TXA to trauma patients.
  • To inform the development of interventions to increase TXA use in emergency medical services.

Main Methods:

  • Conducted semistructured interviews with 18 UK paramedics.
  • Utilized the Theoretical Domains Framework (TDF) to analyze interview data.
  • Employed thematic analysis to identify behavioral theory-derived barriers and facilitators.

Main Results:

  • Eleven TDF domains revealed barriers and facilitators to TXA administration.
  • Key barriers include lack of knowledge/experience, guideline ambiguity, resource constraints, and difficulty identifying bleeding risk.
  • Specific domains affected were Knowledge and Skills, Social/professional role and identity, Environmental context and resources, and Memory, attention and decision processes.

Conclusions:

  • A behavioral theory-based approach identified key factors influencing prehospital TXA administration.
  • Findings provide a foundation for developing targeted interventions to enhance TXA use in trauma care.
  • Addressing identified barriers can improve the effectiveness of emergency medical services in managing traumatic hemorrhage.
Abstract

Related Concept Videos

Barriers to Effective Communication II01:21

Barriers to Effective Communication II

The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
4.0K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
16
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.0K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
121
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
113
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
16